Clinical Study of Endocardial Myocardial Biopsy

Phase 4RecruitingNCT05718128

Second Affiliated Hospital, Zhejiang University, School of Medicine100 enrolled

Overview

In this study, patients with endocardial myocardial biopsy were selected to observe the safety of the operation, and pathological examination was performed. If necessary, special tests such as viral examination, mass spectrometry and molecular biology were performed to confirm the diagnosis, and follow-up was performed.

Study Type

INTERVENTIONAL

Allocation

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

100

Conditions

Myocarditis Cardiomyopathies Heart Failure Cardiac Tumor Endocardiomyocardial Biopsy

Interventions

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with no gender restriction, age 18-80 years old, receiving endocardial myocardial biopsy in the Second Affiliated Hospital of Zhejiang University School of Medicine; * Patients with myocarditis, cardiomyopathy, heart failure and cardiac tumor of unknown clinical cause; * Have the ability to understand the test, can cooperate with investigators. Exclusion Criteria: * Unable to understand or unwilling to fill in informed consent forms or follow visitors.

Outcomes

Primary Outcomes

Incidence of MACE-4

incidences of MACE-4(cardiovascular death, myocardial infarction, stroke and hospitalized unstable angina)

Time frame: 10 year